Andreas Obermair

University of Queensland — Australia

Medicine · Health Sciences

62h-index14.9kcitations458works5.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Endometrial and Cervical Cancer Treatments(171), Ovarian cancer diagnosis and treatment(119), Uterine Myomas and Treatments(74), Endometriosis Research and Treatment(59), Cancer survivorship and care(42)

Publications442 total

Central Pathology Review of Endometrial Hyperplasia and Adenocarcinoma Before and After Treatment With the Levonorgestrel Intrauterine Device–Results From the feMMe Phase 2 Randomized Clinical Trial
The American Journal of Surgical Pathology·2025Open Access
EXERCISE THERAPY ADDED TO FIRST-LINE CHEMOTHERAPY FOR OVARIAN CANCER: EFFECTS ON PROGRESSION-FREE SURVIVAL AND PHYSICAL WELLBEING IN THE RANDOMISED, PHASE 3 ECHO TRIAL (ANZGOG1304/CTC121)
International Journal of Gynecological Cancer·2025
LONG-TERM ONCOLOGICAL AND FERTILITY OUTCOMES FOLLOWING THE LEVONORGESTREL INTRAUTERINE DEVICE IN EARLY-STAGE ENDOMETRIAL ADENOCARCINOMA – RESULTS FROM THE FEMME PHASE II RANDOMISED TRIAL
International Journal of Gynecological Cancer·2025
Diet and Lifestyle Quality in Australian Females with Endometrial Cancer at Diagnosis: Insights from the Fertility-sparing Management for Early Endometrial Cancer (FeMMe) Trial
Current Developments in Nutrition·2025Open Access
Extracellular vesicles as biomarkers for endometrial cancer – A systematic review
Translational Oncology·2025Open Access
Pathologic resection margin status and risk of local recurrence in patients with apparent early-stage squamous cell carcinoma: Results from the International Vulvar Cancer Consortium
Gynecologic Oncology·2025
CN88 A phase II randomized trial of nurse led telehealth follow-up including patient reported outcomes using the MOST-S26 (measure of ovarian symptoms and treatment concerns) versus routine clinic based or telehealth follow-up, after completion of chemotherapy in patients with ovarian cancer
Annals of Oncology·2025
Erratum to ‘Phase 2b, open-label, single-arm, multicenter pilot study of the efficacy, safety, and tolerability of dostarlimab in women with early-stage mismatch repair-deficient endometrioid endometrial adenocarcinoma’ [International Journal of Gynecological Cancer Volume 35 Issue 4 (2025) 101644]
International Journal of Gynecological Cancer·2025Open Access
Development of a novel Classification of intraoperative Adverse Surgical Events (CiASE) in gynaecological cancer surgery
International Journal of Gynecological Cancer·2025
“The telehealth means I get distance from the hospital so I don’t feel so much like a patient”: A qualitative sub-study examining the acceptability of nurse-led follow-up for ovarian cancer via telehealth using the MOST-S26 to structure consultations.
Journal of Clinical Oncology·2025
Green tea consumption, primary treatment outcome and survival after a diagnosis of ovarian cancer
Journal of Epidemiology & Community Health·2025· 1 cited
Phase 2b, open-label, single-arm, multicenter pilot study of the efficacy, safety, and tolerability of dostarlimab in women with early-stage mismatch repair-deficient endometrioid endometrial adenocarcinoma
International Journal of Gynecological Cancer·2025· 3 cited
Long-acting, progestin-based contraceptives and risk of breast, gynecological, and other cancers
JNCI Journal of the National Cancer Institute·2025· 6 citedOpen Access
The impact of surgical adverse events on patient-reported outcomes after gynaecological surgery
2025
Mild symptoms matter: Results from a prospective, longitudinal study on the relationship between symptoms, lymphedema and health-related outcomes post-gynecological cancer
Gynecologic Oncology·2024· 2 citedOpen Access
Outcomes of low-volume metastatic disease among patients with early-stage squamous cell carcinoma undergoing sentinel lymph node biopsy: Results from the International Vulvar Cancer Consortium (IVUCCO)
Gynecologic Oncology·2024
EV430/#358  Benefit-harm trade-off for groin node dissection versus groin ultrasound monitoring to reduce the risk of surgery-related morbidity in vulvar cancer – a decision-tree analysis
2024
The ECHO-R Exercise Trial For Recurrent Ovarian Cancer: Robust Evidence In An Understudied Population
Medicine & Science in Sports & Exercise·2024
Impact of gated FDG PET/CT on the staging of patients with suspected or proven newly diagnosed advanced epithelial ovarian, fallopian tube, and primary peritoneal cancer: results from a non-randomized, phase II clinical trial
International Journal of Gynecological Cancer·2024· 2 cited
Use of menopausal hormone therapy before and after diagnosis and ovarian cancer survival—A prospective cohort study in Australia
International Journal of Cancer·2024Open Access
page 1 of 23Next →

Frequent Co-authors

Monika Janda(14), James Nicklin(10), Val Gebski(9), Yee Leung(9), Martin K. Oehler(8), Alexandra Kaider(8), G. Breitenecker(7), Lewis Perrin(7), Sepp Leodolter(7), Christian Kainz(7), Alison H. Brand(6), Ian Hammond(6), Michael Quinn(6), Penelope M. Webb(6), Robert L. Coleman(5), Georg Oberhuber(5), Tom Manolitsas(5), Anthony J. McCartney(5), Amanda B. Spurdle(5), G. Gitsch(5)